This company listing is no longer active
Xenetic Biosciences 過去の業績
過去 基準チェック /06
Xenetic Biosciences has been growing earnings at an average annual rate of 0.6%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been declining at an average rate of 38.9% per year.
主要情報
0.6%
収益成長率
45.6%
EPS成長率
| Biotechs 業界の成長 | -14.6% |
| 収益成長率 | -38.9% |
| 株主資本利益率 | -45.2% |
| ネット・マージン | -302.3% |
| 前回の決算情報 | 31 Mar 2023 |
最近の業績更新
Recent updates
収支内訳
Xenetic Biosciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 23 | 2 | -6 | 4 | 4 |
| 31 Dec 22 | 2 | -7 | 4 | 5 |
| 30 Sep 22 | 2 | -7 | 4 | 5 |
| 30 Jun 22 | 1 | -7 | 4 | 5 |
| 31 Mar 22 | 1 | -6 | 4 | 4 |
| 31 Dec 21 | 1 | -6 | 4 | 3 |
| 30 Sep 21 | 1 | -5 | 4 | 2 |
| 30 Jun 21 | 1 | -11 | 4 | 2 |
| 31 Mar 21 | 1 | -11 | 3 | 2 |
| 31 Dec 20 | 0 | -11 | 3 | 2 |
| 30 Sep 20 | 0 | -11 | 3 | 2 |
| 30 Jun 20 | 0 | -14 | 4 | 5 |
| 31 Mar 20 | 0 | -14 | 4 | 5 |
| 31 Dec 19 | 0 | -18 | 4 | 5 |
| 30 Sep 19 | 0 | -19 | 4 | 5 |
| 30 Jun 19 | 0 | -10 | 4 | 2 |
| 31 Mar 19 | 0 | -11 | 4 | 3 |
| 31 Dec 18 | 0 | -7 | 4 | 3 |
| 30 Sep 18 | 8 | -1 | 5 | 3 |
| 30 Jun 18 | 8 | -2 | 5 | 3 |
| 31 Mar 18 | 8 | -3 | 6 | 3 |
| 31 Dec 17 | 8 | -4 | 6 | 4 |
| 30 Sep 17 | 3 | -12 | 7 | 4 |
| 30 Jun 17 | 3 | -13 | 7 | 4 |
| 31 Mar 17 | 3 | -58 | 7 | 5 |
| 31 Dec 16 | 3 | -58 | 7 | 4 |
| 30 Sep 16 | 0 | -57 | 6 | 4 |
| 30 Jun 16 | 0 | -60 | 8 | 4 |
| 31 Mar 16 | 0 | -14 | 7 | 3 |
| 31 Dec 15 | 0 | -13 | 7 | 3 |
| 30 Sep 15 | 0 | -13 | 6 | 5 |
| 30 Jun 15 | 0 | -11 | 4 | 6 |
| 31 Mar 15 | 0 | -13 | 5 | 7 |
| 31 Dec 14 | 0 | -14 | 6 | 6 |
| 30 Sep 14 | 0 | -14 | 6 | 4 |
| 30 Jun 14 | 0 | -13 | 6 | 3 |
| 31 Mar 14 | 1 | -11 | 6 | 3 |
| 31 Dec 13 | 1 | -9 | 4 | 3 |
| 30 Sep 13 | 1 | -7 | 5 | 3 |
| 30 Jun 13 | 1 | -6 | 4 | 2 |
| 31 Mar 13 | 0 | -6 | 4 | 2 |
| 31 Dec 12 | 0 | -6 | 4 | 2 |
| 30 Sep 12 | 0 | -6 | 4 | 2 |
質の高い収益: 3XB0 is currently unprofitable.
利益率の向上: 3XB0 is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 3XB0 is unprofitable, but has reduced losses over the past 5 years at a rate of 0.6% per year.
成長の加速: Unable to compare 3XB0's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: 3XB0 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).
株主資本利益率
高いROE: 3XB0 has a negative Return on Equity (-45.22%), as it is currently unprofitable.